Get started
RocketTickers

aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Tr

Long
aTyr Pharma, Inc. (NASDAQ:LIFE)  
RocketTickers  
NASDAQ:LIFE   aTyr Pharma, Inc.
Beyond Technical Analysis
1
0
beyondta
LIFE: aTyr Pharma, Inc.
2021-09-13 07:30:00
aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.